PAPER Pasquali L, Ruffoli R, Fulceri F, Pietracupa S, Siciliano G, Paparelli A, Fornai F
SEARCH RESULTS
329963 RESULTS
PAPER Jenkins TA, Harte MK, Reynolds GP
Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat.
Neurosci Lett. 2010 Mar 8;471(3):144-7. PubMed: 20097262PAPER Gozzi A, Crestan V, Turrini G, Clemens M, Bifone A
Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.
Psychopharmacology (Berl). 2010 Mar;209(1):37-50. PubMed: 20111859PAPER Liu Y, Prasad R, Wilson SH
HMGB1: roles in base excision repair and related function.
Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):119-30. PubMed: 20123074PAPER Grosset D
Parkinson's disease and related disorders--XVIII WFN World Congress.
IDrugs. 2010 Feb;13(2):82-4. PubMed: 20127558PAPER Sen AP, Gulati A
Use of magnesium in traumatic brain injury.
Neurotherapeutics. 2010 Jan;7(1):91-9. PubMed: 20129501PAPER Gupte AA, Morris JK, Zhang H, Bomhoff GL, Geiger PC, Stanford JA
Age-related changes in HSP25 expression in basal ganglia and cortex of F344/BN rats.
Neurosci Lett. 2010 Mar 19;472(2):90-3. PubMed: 20144690PAPER Weisskopf MG, Knekt P, O'Reilly EJ, Lyytinen J, Reunanen A, Laden F, Altshul L, Ascherio A
Persistent organochlorine pesticides in serum and risk of Parkinson disease.
Neurology. 2010 Mar 30;74(13):1055-61. PubMed: 20350979PAPER Heikal AA
Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies.
Biomark Med. 2010 Apr;4(2):241-63. PubMed: 20406068PAPER Ticozzi N, Ratti A, Silani V
Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage.
CNS Neurol Disord Drug Targets. 2010 Jul;9(3):285-96. PubMed: 20406182PAPER Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM
Glucocorticoids, cytokines and brain abnormalities in depression.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):722-9. PubMed: 20406665Robert Cherny
The Mental Health Research InstituteParkville, Australia
PAPER Chertkow H, Nikelski J, Leger G, Litwin L, Whitehead V, Evans A
Using FDG PET and PIB (Pittsburgh B) PET imaging to distinguish atypical Alzheimer’s disease and fronto-temporal dementia cases.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Chau WF, Peterson S, Farrar G, Eko-Ebongue S, Barnes C
Evaluation of metabolites of [18F]flutemetamol, an amyloid imaging agent in human and rat in vitro and rat in vivo models.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;PAPER Carpenter AP, Pontecorvo MJ, Sadowsky C, Hassman HA, Edell S, Clark CM, Hefti F, Joshi A, Burns J, Skovronsky DM
Pharmacokinetics and pharmacodynamics of 18F-AV-45 (florbetapir F 18) PET imaging in Alzheimer’s disease (AD) and healthy control subjects: results of a phase II trial: 18F-AV-45-A03.
Human Amyloid Imaging 2010 Meeting Abstracts. 2010 April 9;Current Filters
No filters selected